Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer.

Pamela Maxwell, Melanie McKechnie, Christopher Armstrong, Chee Wee Ong, David Waugh, Melissa LaBonte Wilson

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2017
EventAACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research - Disney's Boardwalk Inn, Orlando, United States
Duration: 02 Dec 201705 Dec 2017
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=114#.WkzvF7acajg

Conference

ConferenceAACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research
CountryUnited States
CityOrlando
Period02/12/201705/12/2017
Internet address

Cite this

Maxwell, P., McKechnie, M., Armstrong, C., Ong, C. W., Waugh, D., & LaBonte Wilson, M. (2017). Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer.. Poster session presented at AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, United States.
Maxwell, Pamela ; McKechnie, Melanie ; Armstrong, Christopher ; Ong, Chee Wee ; Waugh, David ; LaBonte Wilson, Melissa. / Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer. Poster session presented at AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, United States.
@conference{9fb226d511d547e5a16c30b75f1d6550,
title = "Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer.",
author = "Pamela Maxwell and Melanie McKechnie and Christopher Armstrong and Ong, {Chee Wee} and David Waugh and {LaBonte Wilson}, Melissa",
year = "2017",
language = "English",
note = "AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research ; Conference date: 02-12-2017 Through 05-12-2017",
url = "http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=114#.WkzvF7acajg",

}

Maxwell, P, McKechnie, M, Armstrong, C, Ong, CW, Waugh, D & LaBonte Wilson, M 2017, 'Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer.', AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, United States, 02/12/2017 - 05/12/2017.

Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer. / Maxwell, Pamela; McKechnie, Melanie; Armstrong, Christopher; Ong, Chee Wee; Waugh, David; LaBonte Wilson, Melissa.

2017. Poster session presented at AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, United States.

Research output: Contribution to conferencePoster

TY - CONF

T1 - Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer.

AU - Maxwell, Pamela

AU - McKechnie, Melanie

AU - Armstrong, Christopher

AU - Ong, Chee Wee

AU - Waugh, David

AU - LaBonte Wilson, Melissa

PY - 2017

Y1 - 2017

M3 - Poster

ER -

Maxwell P, McKechnie M, Armstrong C, Ong CW, Waugh D, LaBonte Wilson M. Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer.. 2017. Poster session presented at AACR Special Conference Prostate Cancer: Advances in Basic, Translational and Clinical Research, Orlando, United States.